City Research Online

Items where City Author is "Giorgakoudi, K."

Up a level
Group by: Type | No Grouping
Jump to: Article
Number of items: 6.

Article

Wong, K., Kinsella, N., Seth, J. , Nicol, D., Cahill, D., Kasivisvanathan, R., Withington, J., Moghul, M., Moss, C., Van Hemelrijck, M., Giorgakoudi, K. ORCID: 0000-0002-5925-1846, Cottrell, C., Yates, E., Khoo, V. & James, N. (2023). COmparing Urolift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study. BMJ Open, 13(10), article number e076621. doi: 10.1136/bmjopen-2023-076621

Giorgakoudi, K. ORCID: 0000-0002-5925-1846, Schley, D., Juleff, N. , Gubbins, S. & Ward, J. (2023). The role of Type I interferons in the pathogenesis of foot-and-mouth disease virus in cattle: a mathematical modelling analysis. Mathematical Biosciences, 363, article number 109052. doi: 10.1016/j.mbs.2023.109052

Davies, H., O'Sullivan, C., Al Janabi, H. , Rattue, H., Trotter, C., Giorgakoudi, K. ORCID: 0000-0002-5925-1846, Ramsay, M., Ladhani, S., Lamagni, T., Okike, I., Le Doare, K. & Heath, P. (2022). Comparison of neurodevelopmental outcomes in children with GBS Sepsis and Meningitis. Clinical Infectious Diseases, 75(5), pp. 922-923. doi: 10.1093/cid/ciac318

Hindocha, S., Campbell, D., Ahmed, M. , Giorgakoudi, K. ORCID: 0000-0002-5925-1846, Sharma, B., Yousaf, N., Molyneaux, P., Hunter, B., Kalsi, H., Cui, W., Davidson, M., Bhosle, J., Minchom, A., Locke, I., Mcdonald, F., O'brien, M., Popat, S. & Lee, R. W. (2021). Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management & Resource Implications. Frontiers in Medicine, 8, article number 764563. doi: 10.3389/fmed.2021.764563

Ahmed, N., Giorgakoudi, K. ORCID: 0000-0002-5925-1846, Usuf, E. , Okomo, U., Clarke, E., Kampmann, B., Le Doare, K. & Trotter, C. (2020). Potential cost-effectiveness of a maternal Group B streptococcal vaccine in The Gambia.. Vaccine, 38(15), pp. 3096-3104. doi: 10.1016/j.vaccine.2020.02.071

Giorgakoudi, K. ORCID: 0000-0002-5925-1846, O'Sullivan, C., Heath, P. T. , Ladhani, S., Lamagni, T., Ramsay, M., Al-Janabi, H. & Trotter, C. (2018). Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study. Vaccine, 36(46), pp. 7033-7042. doi: 10.1016/j.vaccine.2018.09.058

This list was generated on Wed May 29 02:58:53 2024 UTC.